mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for IL5RA
Gene summary
Basic gene Info.Gene symbolIL5RA
Gene nameinterleukin 5 receptor, alpha
SynonymsCD125|CDw125|HSIL5R3|IL5R
CytomapUCSC genome browser: 3p26-p24
Type of geneprotein-coding
RefGenesNM_000564.4,
NM_001243099.1,NM_175724.2,NM_175725.2,NM_175726.3,
NM_175727.2,NM_175728.2,
DescriptionCD125 antigenIL-5 receptor subunit alphaIL-5R subunit alphainterleukin 5 receptor type 3interleukin-5 receptor alpha chaininterleukin-5 receptor subunit alpha
Modification date20141207
dbXrefs MIM : 147851
HGNC : HGNC
Ensembl : ENSG00000091181
HPRD : 00998
Vega : OTTHUMG00000090245
ProteinUniProt: Q01344
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_IL5RA
BioGPS: 3568
PathwayNCI Pathway Interaction Database: IL5RA
KEGG: IL5RA
REACTOME: IL5RA
Pathway Commons: IL5RA
ContextiHOP: IL5RA
ligand binding site mutation search in PubMed: IL5RA
UCL Cancer Institute: IL5RA
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for IL5RA
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
Y172L171ICOAD2
K68V67EBRCA1
Y172R174GLUAD1
S115A116SLUSC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for IL5RA
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
S115A116S0.6392426
Y172R174G-1.828544
Y172L171I-1.3347362
K68V67E-1.1756804
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for IL5RA from PDB
PDB IDPDB titlePDB structure
3QT2Structure of a cytokine ligand-receptor complex

Top
Differential gene expression and gene-gene network for IL5RA
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of IL5RA and the right PPI network was created from samples without mutations in the LBS of IL5RA. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for IL5RA
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0000786Abortion, Spontaneous1Biomarker
umls:C0020517Hypersensitivity1Biomarker
umls:C0032285Pneumonia1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for IL5RA
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of IL5RA go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of IL5RA
Multiple alignments for Q01344 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas